Osteoarthritis Treatment Guidelines

First-Line Pharmacologic Treatment

The American Geriatrics Society recommends acetaminophen as the preferred first-line pharmacologic treatment for mild to moderate osteoarthritis pain, with dosing up to 4000 mg daily, considering ≤3000 mg daily in elderly patients for enhanced safety 1, 2, 3
Acetaminophen provides pain relief comparable to NSAIDs without gastrointestinal, platelet, or nephrotoxic effects 1, 2

The American Geriatrics Society suggests establishing core non-pharmacologic treatments first, including a structured exercise program, weight reduction if overweight, and patient education and self-management 4, 3
A structured exercise program, including quadriceps strengthening and aerobic fitness, is recommended as a core non-pharmacologic treatment 4

The treatment algorithm for osteoarthritis with comorbidities involves starting with acetaminophen up to 4000 mg daily, then progressing to topical NSAIDs before oral NSAIDs to minimize systemic exposure 1, 3, 4
Oral NSAIDs should be considered only if acetaminophen and topical agents fail, with careful assessment of cardiovascular, gastrointestinal, and renal risk factors 6, 3

For patients with hypertension, NSAIDs can increase blood pressure and interfere with antihypertensive medications, while acetaminophen does not impair blood pressure control when combined with antihypertensives 6
For patients with renal impairment, NSAIDs carry substantial nephrotoxic risk and should be avoided or used with extreme caution, while acetaminophen is the most appropriate analgesic for patients with renal disease 1, 6
For patients with hepatic impairment, acetaminophen must not exceed 4000 mg daily due to hepatotoxicity risk 1
For patients with diabetes, NSAIDs increase the risk of renal complications, while acetaminophen is the most appropriate initial analgesic for diabetics with osteoarthritis 6

Do not substitute pharmacologic therapy for core non-pharmacologic treatments, as exercise, weight loss, and education are mandatory first-line interventions 4, 3
Avoid high-dose or long-term NSAID use in elderly patients due to substantially elevated risks of GI bleeding, renal insufficiency, and cardiovascular complications 1, 6, 3